Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes ...

Asundexian (Bayer) significantly reduces the risk of ischemic stroke compared with placebo, without increasing the risk of ...

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways A stroke and a heart attack are both life-threatening conditions ...

A meta-analysis looked at people’s genetic profiles and found associations between blood type and risk of early-onset stroke.

The trial met its main safety and efficacy endpoints in participants who experienced a non-cardioembolic ischemic stroke.

Findings are respite for German conglomerate facing sliding sales of blockbuster drugs and US legal challenges ...

Initiation of anticoagulants is not linked to a reduced risk for ischemic stroke in older patients with atrial fibrillation, ...

TAIPEI (Taiwan News) — Taiwan's Lumosa Therapeutics Co. announced Thursday that it has received written guidance from the US ...

Mallory Prince knows what she’s thankful for this Thanksgiving: To be alive. After suffering an ischemic stroke in September, the 38-year-old teacher and mother of one is almost back to her old self, ...

Imperative Care, Inc. announced late-breaking, real-world data from a multicenter review of 124 consecutive ischemic stroke ...

Imperative Care, Inc. today announced the presentation of late-breaking, real-world data from a multi-center review of ischemic stroke patients treated with ADAPT 2.0, a next-generation approach to A ...

Once-daily asundexian 50 mg, on top of antiplatelet therapy, reduced risk for recurrent ischemic stroke after a ...